In Other News

• Genetic Testing Program Expands Detection of Alpha-1 Antitrypsin Deficiency

• Blood Test Predicts Immunotherapy Response in Head and Neck Cancer

• New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs

• Automated Blood Culture System Speeds Detection of Bloodstream Infections

• New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance

• Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer

• 3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer

• AI-Enabled Spatial Multi-Omics Maps Colorectal Tumor Architecture

• Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

• Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

• Bedside CSF Monitor Detects Early Infection in Fluid Drains

• Circulating Tumor DNA Testing Guides Chemotherapy, Reduces Relapse in Colon Cancer

• Saliva-Based Test Detects Biochemical Signs of Sleep Loss

• Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection

• Researchers Uncover Distinct Chromosome Signature in Aggresive ALT Cancers

• Researchers Uncover Distinct Chromosome Signature in Aggresive ALT Cancers

• Blood-Based Method Tracks Gene Activity in the Living Brain

• Genomic Test Guides Chemotherapy Decisions in Early-Stage Breast Cancer

• Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease

• FDA Approval Expands Automated PD-L1 Testing Across Solid Tumors

• Simple Cytogenetic Method Could Improve Classification of ALL Subtypes

• Diazyme Laboratories Acquires Carolina Liquid Chemistries

• Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia